Yu Xiao-Hong, Sun Jing, Wang Yan, Zhou Ya-Bin
Second Department of Cardiovascular, The First Affiliated Hospital of Heilongjiang University of Chinese Medicine, Harbin, China.
Medicine (Baltimore). 2017 May;96(21):e6998. doi: 10.1097/MD.0000000000006998.
This study aimed to explore the related metabolic biomarkers and to observe the effects of Yangxin Decoction (YXD) on plasma metabolism of patients with unstable angina (UA).
In total, 10 patients with UA (intervention group) and 10 healthy participants (control group) were recruited for this study from January 2009 to December 2010. Plasma samples from both groups were analyzed using liquid chromatography mass spectrometry (LC-MS). Principle component analysis (PCA) and partial least squares (PLS) were used to explore the correlations between metabolic markers in patients with UA.
The LC-MS results indicated that the serum levels of 5 potential metabolic markers, namely, ceramide, glycocholic acid, allocholic acid, lithocholic acid, and leukotriene (LT) B4, were significantly higher in the intervention group than those in the control group.
The results of this study demonstrated potential metabolic markers that can be used to distinguish and diagnose patients with UA.
本研究旨在探索相关代谢生物标志物,并观察养心汤(YXD)对不稳定型心绞痛(UA)患者血浆代谢的影响。
2009年1月至2010年12月,本研究共招募了10例UA患者(干预组)和10名健康参与者(对照组)。两组的血浆样本均采用液相色谱质谱联用仪(LC-MS)进行分析。主成分分析(PCA)和偏最小二乘法(PLS)用于探索UA患者代谢标志物之间的相关性。
LC-MS结果表明,干预组中5种潜在代谢标志物,即神经酰胺、甘氨胆酸、别胆酸、石胆酸和白三烯(LT)B4的血清水平显著高于对照组。
本研究结果证明了可用于区分和诊断UA患者的潜在代谢标志物。